Flagyl 500mg/100ml IV Injection (Metronidazole)

Drug Class: Nitroimidazole Antibiotic & Antiprotozoal | Form: Intravenous (IV) Infusion | Prescription Status: Prescription Only (Rx) — DRAP Registered

What is Flagyl 500mg/100ml IV Injection?

Flagyl 500mg/100ml IV Injection is the intravenous formulation of Metronidazole — the most powerful and fastest-acting delivery form of this essential antibiotic and antiprotozoal medicine. Each ready-to-use bag or bottle contains 500mg of Metronidazole dissolved in 100ml of infusion solution, administered directly into a vein as a slow intravenous drip over 20 to 30 minutes.

This injectable formulation is reserved for the most serious, life-threatening, and complex anaerobic bacterial infections (انتہائی شدید بیکٹیریل انفیکشن) that require immediate, guaranteed, and high-concentration antibiotic delivery — situations where oral tablets or suspension are either insufficient, too slow, or simply not possible. This includes critically ill patients in intensive care, patients who cannot take anything by mouth after surgery, and those with rapidly spreading infections of the abdomen, bloodstream, brain, or genital tract.

Flagyl IV is also one of the most widely used medicines for preventing post-surgical infections — given as a single prophylactic infusion before abdominal, gynaecological, and colorectal surgery to protect patients from serious anaerobic bacterial contamination during the procedure. Because the infusion delivers Metronidazole directly into the bloodstream, it achieves full therapeutic blood levels within minutes — far faster than any oral form — making it the first choice when speed and certainty of antibiotic delivery are clinically critical.

This medicine is strictly a hospital-only formulation and must be prepared and administered exclusively by trained nurses and doctors in a clinical setting.

What is Flagyl 500mg/100ml IV Injection Used For?

Flagyl 500mg/100ml IV Injection is approved for the treatment and prevention of the following serious infections:

• Abdominal and intra-abdominal infections:
  • Peritonitis — severe bacterial infection of the abdominal cavity lining (پیٹ کی جھلی کا شدید انفیکشن)
  • Intra-abdominal abscesses — localised pus-filled bacterial infections within the abdomen
  • Post-operative abdominal infections — serious wound and cavity infections following abdominal surgery
• Gynaecological infections:
  • Endometritis — bacterial infection of the uterine lining (رحم کی اندرونی جھلی کا انفیکشن)
  • Pelvic inflammatory disease (PID) — serious infection of the female reproductive organs
  • Post-partum infections — serious bacterial infections following childbirth
  • Post-surgical gynaecological infections — infections following hysterectomy or other pelvic procedures
• Bacterial septicaemia:
  • Anaerobic bacterial sepsis — life-threatening infection of the bloodstream by anaerobic bacteria (خون میں شدید بیکٹیریل انفیکشن)
• Central nervous system infections:
  • Meningitis — bacterial infection of the membranes surrounding the brain and spinal cord caused by anaerobic organisms (دماغ کا پردہ انفیکشن)
  • Brain abscess — localised pus-filled infection within the brain tissue — Metronidazole is one of the few antibiotics that crosses the blood-brain barrier effectively enough to treat this condition
• Bone and joint infections:
  • Osteomyelitis — anaerobic bacterial bone infection (ہڈی کا انفیکشن) requiring high-dose injectable antibiotic treatment
  • Septic arthritis — anaerobic bacterial joint infection
• Lung and respiratory infections:
  • Lung abscess — pus-filled bacterial cavity within lung tissue caused by anaerobic organisms
  • Aspiration pneumonia — serious lung infection caused by anaerobic bacteria from inhaled oral or gastric contents
• Skin and soft tissue infections:
  • Necrotising fasciitis — rapidly life-threatening bacterial infection destroying skin and deep soft tissue (جلد اور پٹھوں کا تیزی سے پھیلنے والا انفیکشن)
  • Severe cellulitis and deep wound infections involving anaerobic bacteria
• Surgical prophylaxis:
  • Pre-operative prevention of post-surgical infection in abdominal, colorectal, gynaecological, and orthopaedic surgeries — one of the most common uses in Pakistani hospitals
• Pseudomembranous colitis:
  • Serious gut infection caused by Clostridioides difficile when IV treatment is required

How Does Flagyl 500mg/100ml IV Injection Work?

Metronidazole IV works through the same targeted and highly selective mechanism as the oral formulations — but with the critical advantage of immediate, complete, and guaranteed drug delivery directly into the bloodstream:

Once infused into the vein, Metronidazole is immediately distributed throughout all body compartments — including the bloodstream, abdominal fluid, brain and spinal fluid (CSF), bone tissue, lung tissue, and pelvic organs. Inside anaerobic bacteria and protozoan parasites, Metronidazole undergoes a chemical activation process — converting into a highly reactive toxic form that directly attacks and fragments the DNA of the infecting organism. Without intact DNA, bacteria and parasites cannot replicate, repair themselves, or survive, and they rapidly die.

Critical advantages of the IV route for severe infections:

• Immediate therapeutic levels — full antibiotic blood concentrations are achieved within minutes of starting the infusion, compared to 1 to 2 hours with oral forms — critical in life-threatening sepsis, meningitis, and necrotising infections where every minute matters
• Guaranteed delivery — the complete dose enters the bloodstream directly, with no dependence on gut absorption, no risk of vomiting reducing the dose, and no uncertainty about oral bioavailability in critically ill patients
• Superior deep tissue penetration — even at standard doses, IV Metronidazole achieves exceptionally high concentrations in the brain and CSF, abdominal and peritoneal fluid, bone tissue, and pelvic organs — the sites where the most serious anaerobic infections occur
• Reliable surgical prophylaxis — a single pre-operative IV infusion completed 30 to 60 minutes before the first incision ensures maximum antibiotic concentrations are present in all tissues at the moment of highest contamination risk

Dosage and Administration

⚠️ Flagyl 500mg/100ml IV Injection is strictly a hospital-only medicine. It must be prepared, checked, and administered exclusively by qualified nurses and doctors in a clinical setting. It is never used outside a hospital environment.

Paediatric IV Dosing:

• Usual dose: 7.5mg per kg of body weight per dose, administered every 8 hours
• Maximum single dose: 500mg
• For surgical prophylaxis in children: 7.5mg/kg given as a single infusion 30 to 60 minutes before the procedure
• The paediatrician and clinical pharmacist will calculate and verify the exact dose based on the child's weight and clinical condition

Administration Guidelines:

• Administer as a slow IV infusion over 20 to 30 minutes — never as a rapid bolus injection
• The 500mg/100ml formulation is ready to use — no further dilution is required before administration
• Administer through a dedicated IV line or ensure thorough flushing of the line before and after infusion when sharing access with other IV medicines
• Monitor the patient throughout the infusion for signs of infusion-related reactions
• Transition to oral Flagyl (tablet or suspension) as soon as the patient's clinical condition permits oral intake — IV treatment should be used for the shortest time necessary

Active Ingredient

Who Should NOT Receive Flagyl 500mg/100ml IV Injection?

Do not administer this injection if the patient:

• Is allergic to Metronidazole or any other nitroimidazole medicine (such as Tinidazole or Ornidazole)
• Has a history of blood disorders or bone marrow suppression
• Is currently taking Disulfiram or has taken it within the last 2 weeks — a dangerous and severe neurological interaction exists
• Is in the first trimester of pregnancy — unless the life-threatening severity of the infection leaves no safer alternative

Always inform the treating doctor before administration if the patient has any of the following:

• Severe liver disease — Metronidazole is metabolised by the liver; severe hepatic impairment causes significant accumulation, requiring major dose reduction and very close monitoring
• Kidney disease — monitoring is recommended during prolonged IV courses as Metronidazole metabolites may accumulate
• History of seizures or epilepsy — Metronidazole can lower the seizure threshold, particularly at high doses or with rapid infusion
• Existing peripheral neuropathy — numbness or tingling in hands and feet; prolonged IV Metronidazole can worsen this condition
• Hepatic encephalopathy — patients with liver-related brain complications are at higher risk of neurological side effects from IV Metronidazole
• Is pregnant (second or third trimester) — use only when the severity of infection means benefit clearly outweighs risk; always reassess the need for IV Metronidazole in pregnant patients
• Is breastfeeding — breastfeeding should be paused during IV treatment and for 24 to 48 hours after the last dose

Side Effects

Flagyl IV is generally well tolerated under close hospital monitoring. The IV route carries a slightly higher risk of certain neurological side effects compared to oral forms, particularly with high doses or prolonged courses.

Common Side Effects:

• Metallic or bitter taste in the mouth (منہ میں کڑوا ذائقہ) — characteristic of Metronidazole even when given intravenously; harmless and temporary
• Nausea or mild stomach discomfort — less common with IV than oral forms but still possible
• Mild headache or dizziness
• Dark or reddish-brown urine — harmless discolouration from Metronidazole metabolites; not a sign of kidney damage
• Mild skin rash or itching
• Dry mouth
• Temporary and usually reversible elevation of liver enzyme levels on blood tests

Infusion-Related Side Effects:

• Pain, redness, or irritation along the vein during infusion — particularly if the infusion runs too quickly
• Thrombophlebitis — inflammation, redness, and hardness along the vein — the IV site should be changed if this develops
• Feeling of warmth or flushing during infusion

Serious Side Effects — Inform Medical Team Immediately:

• Neurological effects — numbness, tingling, or burning in hands or feet (peripheral neuropathy); confusion; unsteady walking; slurred speech; visual disturbances — stop infusion and inform the doctor immediately; prolonged high-dose IV use carries a real risk of neurological damage
• Seizures or fits — particularly at high doses, in patients with liver disease, or those with pre-existing neurological conditions — requires immediate medical management (یہ طبی ہنگامی صورتحال ہے)
• Severe allergic reaction — sudden rash, hives, swelling of the face, lips, tongue or throat, difficulty breathing, or circulatory collapse — requires immediate emergency intervention
• Severe skin reaction — widespread blistering or peeling skin — rare but a medical emergency
• Signs of liver damage — yellowing of skin or eyes (یرقان / jaundice), very dark urine, severe abdominal pain, extreme fatigue — immediate medical evaluation required
• Signs of blood disorder — unusual or excessive bruising, persistent unexplained sore throat, severe fatigue, or fever — possible with prolonged IV courses; requires blood count evaluation
• Worsening encephalopathy — confusion, disorientation, or altered consciousness — particularly in patients with pre-existing liver disease

If any serious side effect occurs during or after infusion, the attending medical team must be informed and emergency intervention initiated immediately.

Drug and Substance Interactions

The treating doctor and clinical pharmacist must be fully informed of all medicines the patient is currently receiving before Flagyl IV infusion is initiated.

Storage Instructions

• Store unopened bags below 25°C in a cool, dry place protected from direct sunlight — do not refrigerate or freeze the infusion bags
• Protect from light — Metronidazole infusion bags should be stored away from direct light exposure; some formulations are supplied in light-protective outer packaging
• Keep out of reach of children (بچوں کی پہنچ سے دور رکھیں)
• Inspect the bag carefully before use — check for leaks, cracks, particulate matter, cloudiness, or discolouration; discard immediately if any abnormality is found; never use a bag that has been previously opened or partially used
• Use immediately once the bag seal is opened — do not store a partially used infusion bag for later use under any circumstances
• Do not use after the expiry date printed on the infusion bag label or outer packaging
• Follow hospital pharmacy and clinical guidelines for disposal of used IV bags and infusion equipment

Frequently Asked Questions

Why is Flagyl IV used instead of Flagyl tablets for serious infections?

When an infection is life-threatening — such as septicaemia, brain abscess, necrotising fasciitis, or severe peritonitis — there is no time to wait for oral absorption. Flagyl IV achieves full therapeutic blood levels within minutes of starting the infusion, compared to 1 to 2 hours with tablets. Additionally, critically ill patients are often unable to swallow, unconscious, post-operative, or vomiting — making oral administration impossible. The IV route guarantees the full dose reaches the bloodstream regardless of the patient's digestive function or level of consciousness.

How long is a typical course of Flagyl IV treatment?

Duration varies considerably based on the infection being treated. For surgical prophylaxis, a single pre-operative infusion is usually sufficient. For serious infections such as peritonitis or gynaecological infections, a course of 7 to 14 days is typical. Brain abscesses and bone infections may require much longer courses — sometimes 4 to 6 weeks. In most cases, doctors aim to switch from IV to oral Flagyl tablets as soon as the patient's clinical condition allows oral intake, as the oral form is equally effective once the acute phase is controlled and is associated with fewer infusion-related complications.

Why is Flagyl IV particularly effective for brain abscesses?

Metronidazole has an exceptional ability to cross the blood-brain barrier — the protective filter that prevents most medicines and substances from entering the brain from the bloodstream. Many antibiotics cannot achieve therapeutic concentrations in the brain tissue or cerebrospinal fluid. Metronidazole crosses this barrier readily and achieves concentrations in brain tissue that are close to its blood levels — making it one of the very few antibiotics that can effectively treat anaerobic bacterial infections within the brain itself. This is why it is a critical component of brain abscess treatment protocols.

Can Flagyl IV be mixed with other IV medicines in the same line?

Metronidazole IV has known compatibility issues with several other IV medicines and must never be mixed directly in the same bag. Most importantly, it must not be administered simultaneously through the same IV line as medicines it is known to be physically or chemically incompatible with — including certain antibiotics, high-pH medicines, and some chemotherapy agents. The IV line must be thoroughly flushed with compatible fluid before and after each Metronidazole infusion when the same access point is shared. The clinical pharmacist will advise on compatibility with the patient's complete IV regimen.

Is Flagyl IV safe for pregnant women in an emergency?

In the first trimester, Metronidazole IV should be avoided unless no safer alternative exists and the infection poses an immediate threat to the mother's life. In the second and third trimesters, it may be used when the severity of anaerobic infection — such as severe peritonitis, endometritis following delivery, or life-threatening sepsis — means the benefit to the mother clearly and substantially outweighs any potential risk. The decision must be made by a senior obstetrician and infectious disease specialist together, with continuous monitoring of both mother and foetal condition throughout treatment.

Why must Flagyl IV be infused slowly over 20 to 30 minutes?

Rapid infusion of Metronidazole IV carries a significantly higher risk of neurological side effects — particularly seizures — as well as cardiovascular effects including sudden drops in blood pressure. Administering it as a slow infusion over the recommended 20 to 30 minutes maintains a steady, controlled rate of drug entry into the bloodstream, minimising peak concentration spikes that trigger these adverse effects. The infusion rate is set and monitored by the attending nurse and must never be increased to save time.

---

⚕️ Medical Disclaimer: This product description is provided for general informational purposes only and does not replace professional medical advice, diagnosis, or treatment. Flagyl 500mg/100ml IV Injection is a prescription-only hospital medicine that must be administered exclusively by qualified healthcare professionals under strict clinical supervision. Any adverse reactions or unexpected symptoms during or after infusion must be reported to the medical team immediately.

---

DRAP Registered | Prescription Required (Rx) | For hospital use under strict medical supervision only — administer as slow IV infusion over 20 to 30 minutes — never for home use